evidencegaps
Primary study · included by 1 review

Insulin glargine and cancer risk in patients with diabetes: a meta-analysis.

Tang 2012 · Tang Xulei, Yang Lin, He Zhiyu, et al. · PloS one · 2012

Included by

Bladder cancer risk factors: a comprehensive umbrella review of meta-analyses.
Non-Cochrane · aetiology · 2026 · cited as Tang 2012 · Table 1 (Included MA); References
Outcome this study informsPooled effectEvidenceCertainty
Risk of bladder cancer
With insulin glargine vs Without insulin glargine
OR 0.6 [0.37, 0.99]4 studies · 75702 participantsVery low
Risk of bladder cancer
With 5-alpha reductase inhibitors vs Without 5-alpha reductase inhibitors
OR 0.75 [0.64, 0.88]4 studies · 180829 participantsLow

1 including review in total.